Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome 2020-11-26 10:32
Frost & Sullivan Examines 8 Strategic Imperatives for Growth in a Post-COVID World 2020-11-26 01:23
Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres® Y-90 resin microspheres milestone 2020-11-26 01:17
RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA 2020-11-25 16:06
Indonesia's Government to Help Improve the Welfare of Non-Civil Servant Educators and Educational Personnel Through Wage Subsidies 2020-11-25 13:11
Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2020-11-25 08:27
MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients 2020-11-25 08:00
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Awardees of the Seoul Innovation QuickFire Challenge on Healthcare for the New Normal in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute 2020-11-25 07:00
RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences 2020-11-25 07:00
Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2020-11-25 06:00
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021 2020-11-25 05:16
The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets 2020-11-25 04:38
PwC Actuarial Services Hails Aon's PathWise® Platform for IFRS 17 Reporting 2020-11-24 23:00
Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose 2020-11-24 22:14
World's Airports And Leading Airlines Join CommonTrust Network And Begin Roll-out Of CommonPass In December In Support Of Safer Border Reopening 2020-11-24 22:09
INSIGHTEC Announces MR-guided Focused Ultrasound to Treat Essential Tremor Received Funding by National Health Service (NHS) England 2020-11-24 19:00
TUV Rheinland Named Mercer China Top Healthiest Workplace 2020-11-24 18:28
TOP 6 Beauty Trends of 2020 -- Revel in the most celebrated trends and product innovations unveiled in CosmoTrends 2020-11-24 18:07
Pine Care Group announces its 2020 Interim Results 2020-11-24 17:57
Online 2020 Gangnam Medi Tour Festa to be Held Until Dec. 31 2020-11-24 16:19
1 397 398 399 400 401 742